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The *Vibrio* genus contains over 140 different species, including *Vibrio cholerae*, the causative agent of cholera. This species alone harbors over 200 different serogroups based on the O antigen, several of which are associated with human infections ([@B1]). Here, we describe a potentially novel *Vibrio* species, *Vibrio* sp. strain 2521-89, which is a close relative of *Vibrio cholerae* but is markedly divergent from it.

Genomic DNA was extracted using an ArchivePure DNA cell/tissue kit (5 PRIME) according to the manufacturer's instructions. Sequencing libraries were prepared using the RSII SMRTbell template preparation kit 1.0 (PacBio) and sequenced with the P6v2 single-molecule real-time (SMRT) sequencing platform (PacBio). The complete genome has a total size of 4,123,863 bp and consists of two chromosomes (3,017,468 bp and 1,106,395 bp). The DNA G+C content was determined to be 47.2 mol%. Genome annotation was done using RAST 2.0 ([@B2]) and the Prokaryotic Genome Annotation Pipeline (PGAP) (<https://www.ncbi.nlm.nih.gov/genome/annotation_prok/>). PGAP annotations identified 3,814 coding sequences, 31 rRNA sequences (11 5S rRNA, 10 16S rRNA, and 10 23S rRNA sequences), and 104 tRNA sequences. *Vibrio* sp. 2521-89 contains genes encoding the transcriptional activator ToxR protein, one of the major regulators of virulence genes in *V. cholerae* ([@B3]), but it lacks both genes encoding the cholera toxin and the toxin-coregulated pilus cluster.

Species identity was determined by calculating average nucleotide identity (ANI) and *in silico* digital DNA-DNA hybridization (dDDH) between *Vibrio* sp. 2521-89 and *V. cholerae* N16961, *Vibrio metoecus* OP3H, or *Vibrio mimicus* CAIM 602 using JSpecies 1.2.1 ([@B4]) and GGDC 2.1 ([@B5]), respectively. *Vibrio* sp. 2521-89 has an ANI value of 95.1% with *V. cholerae* N16961 and values ranging from 84.8% to 87.9% with other closely related *Vibrio* species. Its dDDH value with *V. cholerae* N16961 is 61.8% (58.9% to 64.6% range, with 95% confidence interval), compared to less than 32.6% with other *Vibrio* species. Despite the ANI value being borderline to the 95% species cutoff ([@B6]), a dDDH value well below the 70% species cutoff ([@B7]) suggests that *Vibrio* sp. 2521-89 is potentially a novel species. Parsnp 1.2 ([@B8]) was used to perform core-genome single-nucleotide polymorphism (SNP)-based phylogenetic analysis of *Vibrio* sp. 2521-89 and closely related vibrios. This analysis showed the novel strain grouping strongly in a monophyletic cluster with *V. cholerae* isolates, albeit displaying an unusually long branch length, possibly representing a speciation event.
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The complete genome sequence of *Vibrio* sp. 2521-89 has been deposited in GenBank under the accession numbers [CP022353](https://www.ncbi.nlm.nih.gov/nuccore/CP022353) (chromosome I) and [CP022352](https://www.ncbi.nlm.nih.gov/nuccore/CP022352) (chromosome II). The versions described in this paper are the first versions, CP022353.1 and CP022352.1, respectively.
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